Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3027% below fair value
$18.32−0.35 (-1.87%)
Close on Nov 17, 2026Market cap $3.16BP/E 8.3Yield –
Acadia Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Acadia Pharmaceuticals's price to book ratio was 2.4× on Nov 11, 2026, against 4.6× a year earlier. Over the last 5 years it ranged from 2.4× to 14.2×, with a median of 5.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.4× | −2.5 |
| 2025 | Dec 31, 2025 | 4.9× | −0.4 |
| 2024 | Dec 31, 2024 | 5.3× | −8.9 |
| 2023 | Dec 29, 2023 | 14.2× | +8.1 |
| 2022 | Dec 30, 2022 | 6.1× | −0.6 |
| 2021 | Dec 31, 2021 | 6.6× | −6.4 |
| 2020 | Dec 31, 2020 | 13.0× | +3.4 |
| 2019 | Dec 31, 2019 | 9.5× | +0.5 |
| 2018 | Dec 31, 2018 | 9.0× | −0.7 |
| 2017 | Dec 29, 2017 | 9.8× | +3.8 |
| 2016 | Dec 30, 2016 | 6.0× | −9.8 |
| 2015 | Dec 31, 2015 | 15.8× | +6.2 |
| 2014 | Dec 31, 2014 | 9.6× | −2.7 |
| 2013 | Dec 31, 2013 | 12.3× | −2.6 |
| 2012 | Dec 31, 2012 | 14.9× | +12.9 |
| 2011 | Dec 30, 2011 | 2.0× | −1.7 |
| 2010 | Dec 31, 2010 | 3.7× | – |
See a number that looks wrong?